Analysts Offer Predictions for CME Group FY2024 Earnings

CME Group Inc. (NASDAQ:CME) – Analysts at Zacks Research issued their FY2024 EPS estimates for shares of CME Group in a research report issued to clients and investors on Wednesday, November 13th. Zacks Research analyst T. De forecasts that the financial services provider will post earnings of $10.21 per share for the year. The consensus estimate for CME Group’s current full-year earnings is $10.22 per share. Zacks Research also issued estimates for CME Group’s Q4 2025 earnings at $2.56 EPS.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period last year, the business posted $2.25 earnings per share.

CME has been the subject of several other research reports. Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Keefe, Bruyette & Woods increased their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Oppenheimer boosted their price objective on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Citigroup lifted their target price on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $224.47.

CME Group Trading Up 0.8 %

Shares of CME Group stock opened at $225.28 on Monday. The stock has a market capitalization of $81.18 billion, a P/E ratio of 23.69, a P/E/G ratio of 5.20 and a beta of 0.55. CME Group has a 52-week low of $190.70 and a 52-week high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50-day simple moving average is $222.62 and its 200 day simple moving average is $210.39.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its holdings in shares of CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after purchasing an additional 142,692 shares during the last quarter. Brophy Wealth Management LLC purchased a new stake in CME Group during the third quarter valued at about $596,000. Vestcor Inc boosted its position in CME Group by 2.8% during the third quarter. Vestcor Inc now owns 14,478 shares of the financial services provider’s stock valued at $3,195,000 after buying an additional 399 shares during the period. M&T Bank Corp grew its stake in shares of CME Group by 10.3% during the third quarter. M&T Bank Corp now owns 96,069 shares of the financial services provider’s stock valued at $21,198,000 after buying an additional 8,968 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. increased its holdings in shares of CME Group by 19.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 354,421 shares of the financial services provider’s stock worth $78,203,000 after buying an additional 58,221 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 15.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last quarter. Corporate insiders own 0.30% of the company’s stock.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s payout ratio is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.